Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2014

01-12-2014 | Original Article

Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis

Authors: Y. Xiao, J. Zhang, X. He, J. Ji, G. Wang

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2014

Login to get access

Abstract

Aim

A meta-analysis was performed to assess the diagnostic values of carcinoembryonic antigen (CEA) in predicting the peritoneal recurrence after curative resection of gastric cancer.

Methods

The Medline, Embase, Web of Science, Ovid and Cochrane databases, Google Scholar and Vivisimo engines were searched to identify studies reporting on the accuracy of CEA protein or CEA mRNA in predicting the postoperative peritoneal recurrence of gastric cancer. Publication bias was demonstrated by Funnel plots and Egger test. The sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated and summary receiver operating characteristic curves were generated.

Results

Seven and eight studies fulfilled the inclusion criteria for CEA protein and mRNA determination, including 635 and 849 patients, respectively. The pooled sensitivity, specificity and DOR of CEA protein for predicting the peritoneal recurrence were 0.77 (95 % CI 0.69–0.84), 0.89 (95 % CI 0.86–0.92), 29.71 (95 % CI 10.27–85.92), respectively. Similarly, the values for CEA mRNA were 0.82 (95 % CI 0.75–0.88), 0.82 (95 % CI 0.79–0.85) and 22.97 (95 % CI 10.90–48.41). Meanwhile, the sensitivity and DOR of CEA protein or mRNA were higher than those of cytology, while higher specificity was noted in cytology assay.

Conclusion

CEA protein and mRNA levels in peritoneal lavage show a high diagnostic accuracy and may help accurately predict the peritoneal recurrence after curative resection of gastric cancer.
Literature
1.
go back to reference GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T et al (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303(17):1729–1737PubMedCrossRef GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T et al (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303(17):1729–1737PubMedCrossRef
2.
go back to reference Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8(1):1–11PubMedCrossRef Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8(1):1–11PubMedCrossRef
3.
go back to reference Kaibara N, Iitsuka Y, Kimura A et al (1987) Relationship between area of serosal invasion and prognosis in patient with gastric carcinoma. Cancer 60(1):136–139PubMedCrossRef Kaibara N, Iitsuka Y, Kimura A et al (1987) Relationship between area of serosal invasion and prognosis in patient with gastric carcinoma. Cancer 60(1):136–139PubMedCrossRef
4.
go back to reference Maehara Y, Moriguchi S, Kakeji Y et al (1991) Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 110(5):820–823PubMed Maehara Y, Moriguchi S, Kakeji Y et al (1991) Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 110(5):820–823PubMed
5.
go back to reference Noda S, Soejima K, Inokuchi K (1980) Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn J Surg 10(4):277–283PubMedCrossRef Noda S, Soejima K, Inokuchi K (1980) Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn J Surg 10(4):277–283PubMedCrossRef
6.
go back to reference Saito H, Tsujitani S, Maeda Y et al (2001) Combined resection of invaded organs in patients with T4 gastric carcinoma. Gastric Cancer 4(4):206–211PubMedCrossRef Saito H, Tsujitani S, Maeda Y et al (2001) Combined resection of invaded organs in patients with T4 gastric carcinoma. Gastric Cancer 4(4):206–211PubMedCrossRef
7.
go back to reference To EM, Chan WY, Chow C et al (2003) Gastric cancer cell detection in peritoneal washing: cytology versus RT-PCR for CEA transcripts. Diagn Mol Pathol 12(2):88–95PubMedCrossRef To EM, Chan WY, Chow C et al (2003) Gastric cancer cell detection in peritoneal washing: cytology versus RT-PCR for CEA transcripts. Diagn Mol Pathol 12(2):88–95PubMedCrossRef
8.
go back to reference Boku T, Nakane Y, Minoura T et al (1990) Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77(4):436–439PubMedCrossRef Boku T, Nakane Y, Minoura T et al (1990) Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77(4):436–439PubMedCrossRef
9.
go back to reference Bonenkamp JJ, Songun I, Hermans J et al (1996) Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 83(5):672–674PubMedCrossRef Bonenkamp JJ, Songun I, Hermans J et al (1996) Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 83(5):672–674PubMedCrossRef
10.
go back to reference Schott A, Vogel I, Krueger U et al (1998) Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 227(3):372–379PubMedPubMedCentralCrossRef Schott A, Vogel I, Krueger U et al (1998) Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 227(3):372–379PubMedPubMedCentralCrossRef
11.
go back to reference Bando E, Yonemura Y, Takeshita Y et al (1999) Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 178(3):256–262PubMedCrossRef Bando E, Yonemura Y, Takeshita Y et al (1999) Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 178(3):256–262PubMedCrossRef
12.
go back to reference Suzuki T, Ochiai T, Hayashi H et al (1999) Peritoneal lavage cytology findings as prognostic factor for gastric cancer. Semin Surg Oncol 17(2):103–107PubMedCrossRef Suzuki T, Ochiai T, Hayashi H et al (1999) Peritoneal lavage cytology findings as prognostic factor for gastric cancer. Semin Surg Oncol 17(2):103–107PubMedCrossRef
13.
go back to reference Mori K, Aoyagi K, Ueda T et al (2004) Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem Biophys Res Commun 313(4):931–937PubMedCrossRef Mori K, Aoyagi K, Ueda T et al (2004) Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem Biophys Res Commun 313(4):931–937PubMedCrossRef
14.
go back to reference Tsutsumi S, Asao T, Shimura T et al (2000) A novel rapid colorimetric assay of carcinoembryonic antigen levels in the abdominal cavity to detect peritoneal micrometastasis during gastric cancer surgery. Cancer Lett 149(1–2):1–5PubMedCrossRef Tsutsumi S, Asao T, Shimura T et al (2000) A novel rapid colorimetric assay of carcinoembryonic antigen levels in the abdominal cavity to detect peritoneal micrometastasis during gastric cancer surgery. Cancer Lett 149(1–2):1–5PubMedCrossRef
15.
go back to reference Abe N, Watanabe T, Toda H et al (2001) Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer. Am J Surg 181(4):356–361PubMedCrossRef Abe N, Watanabe T, Toda H et al (2001) Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer. Am J Surg 181(4):356–361PubMedCrossRef
16.
go back to reference Kodera Y, Nakanishi H, Ito S et al (2002) Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg 235(4):499–506PubMedPubMedCentralCrossRef Kodera Y, Nakanishi H, Ito S et al (2002) Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg 235(4):499–506PubMedPubMedCentralCrossRef
17.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE et al (2003) Standards for reporting of diagnostic accuracy towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326(7379):41–44PubMedPubMedCentralCrossRef Bossuyt PM, Reitsma JB, Bruns DE et al (2003) Standards for reporting of diagnostic accuracy towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326(7379):41–44PubMedPubMedCentralCrossRef
18.
go back to reference Whiting P, Rutjes AW, Reitsma JB et al (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25PubMedPubMedCentralCrossRef Whiting P, Rutjes AW, Reitsma JB et al (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25PubMedPubMedCentralCrossRef
19.
21.
go back to reference Cetin B, Atalay C, Aslan S et al (2005) Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer. Surg Today 35(11):919–924PubMedCrossRef Cetin B, Atalay C, Aslan S et al (2005) Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer. Surg Today 35(11):919–924PubMedCrossRef
22.
go back to reference Fujii S, Kitayama J, Kaisaki S et al (2002) Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure. J Exp Clin Cancer Res 21(4):547–553PubMed Fujii S, Kitayama J, Kaisaki S et al (2002) Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure. J Exp Clin Cancer Res 21(4):547–553PubMed
23.
go back to reference Ishii T, Fujiwara Y, Ohnaka S et al (2004) Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis. Ann Surg Oncol 11(8):778–785PubMedCrossRef Ishii T, Fujiwara Y, Ohnaka S et al (2004) Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis. Ann Surg Oncol 11(8):778–785PubMedCrossRef
24.
go back to reference Ito S, Nakanishi H, Kodera Y et al (2005) Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer 93(9):986–992PubMedPubMedCentralCrossRef Ito S, Nakanishi H, Kodera Y et al (2005) Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer 93(9):986–992PubMedPubMedCentralCrossRef
25.
go back to reference Katsuragi K, Yashiro M, Sawada T et al (2007) Prognostic impact of PCR-based identification of isolated tumor cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection. Br J Cancer 97(4):550–556PubMedPubMedCentralCrossRef Katsuragi K, Yashiro M, Sawada T et al (2007) Prognostic impact of PCR-based identification of isolated tumor cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection. Br J Cancer 97(4):550–556PubMedPubMedCentralCrossRef
26.
go back to reference Kodera Y, Nakanishi H, Ito S et al (2006) Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real time reverse transcriptase-polymerase chain reaction after 5 years of followup. J Am Coll Surg 202(2):231–236PubMedCrossRef Kodera Y, Nakanishi H, Ito S et al (2006) Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real time reverse transcriptase-polymerase chain reaction after 5 years of followup. J Am Coll Surg 202(2):231–236PubMedCrossRef
27.
go back to reference Li JK, Zheng M, Miao CW et al (2005) Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer. World J Gastroenterol 11(46):7374–7377PubMed Li JK, Zheng M, Miao CW et al (2005) Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer. World J Gastroenterol 11(46):7374–7377PubMed
28.
go back to reference Nishiyama M, Takashima I, Tanaka T et al (1995) Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg 19(1):133–137PubMedCrossRef Nishiyama M, Takashima I, Tanaka T et al (1995) Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg 19(1):133–137PubMedCrossRef
29.
go back to reference Tokuda K, Natsugoe S, Nakajo A et al (2003) Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer. Int J Mol Med 11(1):79–84PubMed Tokuda K, Natsugoe S, Nakajo A et al (2003) Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer. Int J Mol Med 11(1):79–84PubMed
30.
go back to reference Ueno H, Yoshida K, Hirai T et al (2003) Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction. Anticancer Res 23(2C):1701–1708PubMed Ueno H, Yoshida K, Hirai T et al (2003) Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction. Anticancer Res 23(2C):1701–1708PubMed
31.
go back to reference Wang JY, Lin SR, Lu CY et al (2005) Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels. Cancer Lett 223(1):129–135PubMedCrossRef Wang JY, Lin SR, Lu CY et al (2005) Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels. Cancer Lett 223(1):129–135PubMedCrossRef
32.
go back to reference Yamamoto M, Baba H, Toh Y et al (2007) Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. J Cancer Res Clin Oncol 133(7):471–476PubMedCrossRef Yamamoto M, Baba H, Toh Y et al (2007) Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. J Cancer Res Clin Oncol 133(7):471–476PubMedCrossRef
33.
go back to reference Benevolo M, Mottolese M, Cosimelli M et al (1998) Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol 16(10):3406–3411PubMed Benevolo M, Mottolese M, Cosimelli M et al (1998) Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol 16(10):3406–3411PubMed
34.
go back to reference Wu CC, Chen JT, Chang MC et al (1997) Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg 184(6):611–617PubMed Wu CC, Chen JT, Chang MC et al (1997) Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg 184(6):611–617PubMed
35.
go back to reference Abe S, Yoshimura H, Tabara H et al (1995) Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 59(4):226–229PubMedCrossRef Abe S, Yoshimura H, Tabara H et al (1995) Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 59(4):226–229PubMedCrossRef
36.
go back to reference Juhl H, Stritzel M, Wroblewski A et al (1994) Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57(3):330–335PubMedCrossRef Juhl H, Stritzel M, Wroblewski A et al (1994) Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57(3):330–335PubMedCrossRef
37.
go back to reference Asao T, Fukuda T, Yazawa S et al (1991) Carcinoembryonic antigen levels in peritoneal washings can predict peritoneal recurrence after curative resection of gastric cancer. Cancer 68(1):44–47PubMedCrossRef Asao T, Fukuda T, Yazawa S et al (1991) Carcinoembryonic antigen levels in peritoneal washings can predict peritoneal recurrence after curative resection of gastric cancer. Cancer 68(1):44–47PubMedCrossRef
38.
go back to reference Korenaga D, Okuyama T, Orita H et al (1994) Role of intraoperative assessment of lymph node metastasis and serosal invasion in patients with gastric cancer. J Surg Oncol 55(4):250–254PubMedCrossRef Korenaga D, Okuyama T, Orita H et al (1994) Role of intraoperative assessment of lymph node metastasis and serosal invasion in patients with gastric cancer. J Surg Oncol 55(4):250–254PubMedCrossRef
39.
go back to reference Kodera Y, Nakanishi H, Yamamura Y et al (1998) Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer 79(4):429–433PubMedCrossRef Kodera Y, Nakanishi H, Yamamura Y et al (1998) Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer 79(4):429–433PubMedCrossRef
40.
go back to reference Nakanishi H, Kodera Y, Torii A et al (1997) Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn J Cancer Res 88(7):687–692PubMedCrossRef Nakanishi H, Kodera Y, Torii A et al (1997) Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn J Cancer Res 88(7):687–692PubMedCrossRef
41.
go back to reference Yonemura Y, Endou Y, Fujimura T et al (2001) Diagnostic value of preoperative RT-PCR-based screening method to detect carcinoembryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer. ANZ J Surg 71(9):521–528PubMedCrossRef Yonemura Y, Endou Y, Fujimura T et al (2001) Diagnostic value of preoperative RT-PCR-based screening method to detect carcinoembryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer. ANZ J Surg 71(9):521–528PubMedCrossRef
42.
go back to reference Nakanishi H, Kodera Y, Yamamura Y et al (2000) Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric-cancer patients with real-time RT-PCR on the lightcycler. Int J Cancer 89(5):411–417PubMedCrossRef Nakanishi H, Kodera Y, Yamamura Y et al (2000) Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric-cancer patients with real-time RT-PCR on the lightcycler. Int J Cancer 89(5):411–417PubMedCrossRef
43.
go back to reference Nakanishi H, Kodera Y, Yamamura Y et al (1999) Molecular diagnostic detection of free cancer cells in the peritoneal cavity of patients with gastrointestinal and gynecologic malignancies. Cancer Chemother Pharmacol 43:S32–S36PubMedCrossRef Nakanishi H, Kodera Y, Yamamura Y et al (1999) Molecular diagnostic detection of free cancer cells in the peritoneal cavity of patients with gastrointestinal and gynecologic malignancies. Cancer Chemother Pharmacol 43:S32–S36PubMedCrossRef
44.
go back to reference Kojima N, Kunieda K, Matsui K et al (2003) Evaluation of carcinoembryonic antigen mRNA in living, necrotic, and apoptotic gastric cancer cells by reverse transcriptase-polymerase chain reaction. Surg Today 33(11):839–846PubMedCrossRef Kojima N, Kunieda K, Matsui K et al (2003) Evaluation of carcinoembryonic antigen mRNA in living, necrotic, and apoptotic gastric cancer cells by reverse transcriptase-polymerase chain reaction. Surg Today 33(11):839–846PubMedCrossRef
45.
go back to reference Glas AS, Lijmer JG, Prins MH et al (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56(11):1129–1135PubMedCrossRef Glas AS, Lijmer JG, Prins MH et al (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56(11):1129–1135PubMedCrossRef
Metadata
Title
Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis
Authors
Y. Xiao
J. Zhang
X. He
J. Ji
G. Wang
Publication date
01-12-2014
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2014
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-013-1051-6

Other articles of this Issue 4/2014

Irish Journal of Medical Science (1971 -) 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.